The Second Extracellular Loop of the Adenosine A1 Receptor Mediates Activity of Allosteric Enhancers

被引:16
作者
Kennedy, Dylan P. [1 ]
McRobb, Fiona M. [6 ]
Leonhardt, Susan A. [2 ]
Purdy, Michael [2 ]
Figler, Heidi [2 ]
Marshall, Melissa A. [3 ]
Chordia, Mahendra [2 ]
Figler, Robert [3 ]
Linden, Joel [7 ]
Abagyan, Ruben [2 ,6 ]
Yeager, Mark [2 ,3 ,4 ,5 ]
机构
[1] Univ Virginia Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA
[2] Univ Virginia Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA
[3] Univ Virginia Sch Med, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA
[4] Univ Virginia Sch Med, Ctr Membrane Biol, Charlottesville, VA 22908 USA
[5] Univ Virginia Sch Med, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA
[6] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[7] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
基金
美国国家卫生研究院;
关键词
BIOLOGICAL EVALUATION; ADENOSINE-A1-RECEPTOR BINDING; MUSCARINIC RECEPTORS; GUANINE-NUCLEOTIDE; AGONIST; MODULATION; LIGANDS; GPCRS; 2-AMINO-3-BENZOYLTHIOPHENES; IDENTIFICATION;
D O I
10.1124/mol.113.088682
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Allosteric enhancers of the adenosine A(1) receptor amplify signaling by orthosteric agonists. Allosteric enhancers are appealing drug candidates because their activity requires that the orthosteric site be occupied by an agonist, thereby conferring specificity to stressed or injured tissues that produce adenosine. To explore the mechanism of allosteric enhancer activity, we examined their action on several A(1) receptor constructs, including (1) species variants, (2) species chimeras, (3) alanine scanning mutants, and (4) site-specific mutants. These findings were combined with homology modeling of the A(1) receptor and in silico screening of an allosteric enhancer library. The binding modes of known docked allosteric enhancers correlated with the known structure-activity relationship, suggesting that these allosteric enhancers bind to a pocket formed by the second extracellular loop, flanked by residues S150 and M162. We propose a model in which this vestibule controls the entry and efflux of agonists from the orthosteric site and agonist binding elicits a conformational change that enables allosteric enhancer binding. This model provides a mechanism for the observations that allosteric enhancers slow the dissociation of orthosteric agonists but not antagonists.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 55 条
  • [1] BIASED PROBABILITY MONTE-CARLO CONFORMATIONAL SEARCHES AND ELECTROSTATIC CALCULATIONS FOR PEPTIDES AND PROTEINS
    ABAGYAN, R
    TOTROV, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (03) : 983 - 1002
  • [2] AMOAHAPRAKU B, 1993, J PHARMACOL EXP THER, V266, P611
  • [3] Pocketome via comprehensive identification and classification of ligand binding envelopes
    An, JH
    Totrov, M
    Abagyan, R
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (06) : 752 - 761
  • [4] Allosteric Modulators of the Adenosine A1 Receptor: Synthesis and Pharmacological Evaluation of 4-Substituted 2-Amino-3-benzoylthiophenes
    Aurelio, Luigi
    Valant, Celine
    Flynn, Bernard L.
    Sexton, Patrick M.
    Christopoulos, Arthur
    Scammells, Peter J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4543 - 4547
  • [5] Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor
    Baraldi, PG
    Zaid, AN
    Lampronti, I
    Fruttarolo, F
    Pavani, MG
    Tabrizi, MA
    Shryock, JC
    Leung, E
    Romagnoli, R
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (17) : 1953 - 1957
  • [6] The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs
    Bhattacharya, Samita
    Youkey, Rebecca L.
    Ghartey, Kobina
    Leonard, Matthew
    Linden, Joel
    Tucker, Amy L.
    [J]. BIOCHEMICAL JOURNAL, 2006, 396 : 139 - 146
  • [7] Allosterism at muscarinic receptors: Ligands and mechanisms
    Birdsall, NJM
    Lazareno, S
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) : 523 - 543
  • [8] BRUNS RF, 1990, MOL PHARMACOL, V38, P950
  • [9] BRUNS RF, 1990, MOL PHARMACOL, V38, P939
  • [10] Strategies for the identification of allosteric modulators of G-protein-coupled receptors
    Burford, Neil T.
    Watson, John
    Bertekap, Robert
    Alt, Andrew
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 81 (06) : 691 - 702